EyeGate Pharmaceuticals I... (EYEG)
NASDAQ: EYEG
· Real-Time Price · USD
35.63
-0.08 (-0.22%)
At close: Aug 18, 2025, 3:06 PM
EyeGate Pharmaceuticals Revenue
EyeGate Pharmaceuticals reported an annual revenue of $16.02M, reflecting a 0% growth. For the quarter ending March 31, 2025, EyeGate Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
16.02M
Revenue Growth
n/a
Price / Sales Ratio
8.46
Revenue / Employee
1.14M
Employees
14
Market Cap
26.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 16.02M | +132746.84% |
| Dec 31, 2020 | 12.06K | -99.55% |
| Dec 31, 2019 | 2.69M | +62.54% |
| Dec 31, 2018 | 1.65M | +305.51% |
| Dec 31, 2017 | 407.52K | -39.11% |
| Dec 31, 2016 | 669.26K | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |